NeoVentures announces in-house capacity for the production of recombinant proteins.
NeoVentures is pleased to inform our clients that we are now providing the capacity to generate recombinant proteins for aptamer selection ourselves.
Where the proteins are readily available commercially this is still the best route, but where the proteins are either not available, or where it would be desirable to have recombinant versions of proteins that do contain active domains we will generate these ourselves. We have the capacity to purify the proteins from either E. coli or human cells (preferably HEK293) as appropriate.
This new service offering continues to differentiate NeoVentures from other aptamer companies by the breadth and depth of our understanding of aptamers and our ability to produce aptamers that will perform as you need them to.
For a free consultation on your potential aptamer project please contact us at, email@example.com